OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Providers
  3. Acupath Laboratories, Inc.
🔬
Organization

Acupath Laboratories, Inc.

NPI: 1215921549
Plainview, NY
10 years of data
Clinical Laboratory
$54.1M
Total Payments
267
Beneficiaries
795.0K
Services
1.35x
Markup Ratio

Peer Comparison

98th
percentile in specialty
This provider$54.1M
Specialty median$1.9M
Rank #147 of 232 in specialty

📋 Key Findings

1Billed $54.1M over 10 years
298th percentile in Clinical Laboratory by payments
✓ No flags detected

🔎 Data Analysis

This provider's $54.1M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.

Medicare payments to this provider grew 77% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$103.01$78.611.31x$24.40$3.6M46.3K26
2015$158.99$75.382.11x$83.61$4.1M54.2K26
2016$103.05$80.521.28x$22.53$4.0M49.4K24
2017$94.69$73.021.30x$21.67$3.9M53.9K25
2018$91.14$70.121.30x$21.02$4.2M60.1K28
2019$88.44$68.571.29x$19.87$5.0M72.5K24
2020$93.42$76.471.22x$16.95$6.4M83.2K25
2021$77.13$59.271.30x$17.86$9.1M153.3K29
2022$79.44$60.841.31x$18.60$7.4M121.5K29
2023$84.98$64.221.32x$20.76$6.5M100.5K31

Top Procedures (20)

88305Pathology examination of tissue using a microscope, intermediate complexity
$10.3M
244.8K services$42.03/svc1.53x markup
88312Special stained specimen slides to identify organisms including interpretation and report
$8.6M
106.9K services$80.45/svc1.32x markup
88121Cell examination of urine, computer-assisted
$6.9M
14.8K services$466.20/svc1.33x markup
88313Special stained specimen slides to examine tissue including interpretation and report
$6.8M
108.4K services$62.50/svc1.30x markup
88342Special stained specimen slides to examine tissue, initial procedure
$6.4M
89.7K services$70.86/svc1.38x markup
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
$5.5M
67.2K services$82.00/svc1.10x markup
88341Special stained specimen slides to examine tissue, each additional procedure
$1.5M
19.8K services$74.90/svc1.34x markup
88112Cell examination of specimen, selective cellular enhancement technique
$1.4M
28.9K services$49.16/svc1.46x markup
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
$1.2M
47.5K services$24.92/svc1.00x markup
88173Evaluation of fine needle aspirate with interpretation and report
$801.6K
5.6K services$142.38/svc1.33x markup
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method
$799.5K
2.3K services$344.89/svc1.48x markup
88377Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure
$536.6K
1.6K services$338.98/svc1.41x markup
88185Flow cytometry technique for dna or cell analysis, each additional marker
$510.4K
15.4K services$33.23/svc1.96x markup
88344Special stained specimen slides to examine tissue, each multiplex procedure
$502.4K
3.3K services$150.55/svc1.50x markup
88360Microscopic genetic analysis of tumor, manual
$485.6K
4.6K services$105.26/svc1.38x markup
G0461Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain
$302.0K
5.0K services$60.54/svc1.50x markup
87636Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b
$203.6K
1.5K services$136.75/svc1.39x markup
88304Pathology examination of tissue using a microscope, moderately low complexity
$193.2K
5.1K services$37.72/svc1.47x markup
88366Genetic sequencing localization, each multiplex procedure
$189.1K
741 services$255.20/svc1.24x markup
88120Cell examination of urine, manual
$157.1K
307 services$511.62/svc1.28x markup
Show detailed table ▾
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
88305Pathology examination of tissue using a microscope, intermediate complexity244.8K$10.3M$42.031.53x
88312Special stained specimen slides to identify organisms including interpretation and report106.9K$8.6M$80.451.32x
88121Cell examination of urine, computer-assisted14.8K$6.9M$466.201.33x
88313Special stained specimen slides to examine tissue including interpretation and report108.4K$6.8M$62.501.30x
88342Special stained specimen slides to examine tissue, initial procedure89.7K$6.4M$70.861.38x
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r67.2K$5.5M$82.001.10x
88341Special stained specimen slides to examine tissue, each additional procedure19.8K$1.5M$74.901.34x
88112Cell examination of specimen, selective cellular enhancement technique28.9K$1.4M$49.161.46x
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within47.5K$1.2M$24.921.00x
88173Evaluation of fine needle aspirate with interpretation and report5.6K$801.6K$142.381.33x
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method2.3K$799.5K$344.891.48x
88377Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure1.6K$536.6K$338.981.41x
88185Flow cytometry technique for dna or cell analysis, each additional marker15.4K$510.4K$33.231.96x
88344Special stained specimen slides to examine tissue, each multiplex procedure3.3K$502.4K$150.551.50x
88360Microscopic genetic analysis of tumor, manual4.6K$485.6K$105.261.38x
G0461Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain5.0K$302.0K$60.541.50x
87636Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b1.5K$203.6K$136.751.39x
88304Pathology examination of tissue using a microscope, moderately low complexity5.1K$193.2K$37.721.47x
88366Genetic sequencing localization, each multiplex procedure741$189.1K$255.201.24x
88120Cell examination of urine, manual307$157.1K$511.621.28x

Markup Analysis

Charge-to-Payment Ratio

1.35x

This provider submits charges 1.35 times higher than what Medicare actually pays.

What This Means

A markup ratio of 1.35x means for every $100 Medicare pays, this provider initially charges $135. This is lower than the national average.

Location

Plainview, NY

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Clinical Laboratory providers in NY for peer comparison.

Acupath Laboratories, Inc. (you)
$54.1M
Northwell Health Laboratories⚠️
$299.4M
Sunrise Medical Laboratories, Inc.⚠️
$281.2M
Lenco Diagnostic Laboratories,inc.⚠️
$101.5M
Enzo Clinical Labs, Inc.⚠️
$100.1M
Cblpath, Inc
$94.4M
Show detailed table ▾
ProviderLocationTotal PaymentsStatus
Northwell Health LaboratoriesNew Hyde Park, NY$299.4M⚠️ Flagged
Sunrise Medical Laboratories, Inc.Hicksville, NY$281.2M⚠️ Flagged
Lenco Diagnostic Laboratories,inc.Brooklyn, NY$101.5M⚠️ Flagged
Enzo Clinical Labs, Inc.Farmingdale, NY$100.1M⚠️ Flagged
Cblpath, IncRye Brook, NY$94.4M✓ Clear

Related

Browse
← Back to Provider Directory
State
All providers in NY →
Specialty
All Clinical Laboratory providers →
Tool
Compare this provider →
Analysis
Fraud Watchlist →
Search
Search all providers →

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data